Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2024 financial results
Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today.
Reported sales increased 2.3% year-over-year to $21.4 billion.
The company reported net earnings of $5.3 billion, or $2.20 per share, compared to a loss of $491 million, or $0.19 per share, last year. Adjusted EPS increased 12.4% to $2.71.
Earnings beat expectations while revenues came in line with estimates.
For the full year of 2024, the company expects reported sales to range between $88.0-88.4 billion and adjusted EPS to range between $10.57-10.72.
The stock stayed red in premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three
What to look for when Take-Two Interactive Software (TTWO) reports Q4 2024 earnings results
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) stayed red on Thursday. The stock has dropped 14% over the past three months. The gaming company is scheduled to report its
